The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease
Abstract
Alexander disease is a progressive, usually fatal neurological disorder defined by the widespread and abundant presence in astrocytes of protein aggregates called Rosenthal fibers. The disease most often occurs in infants younger than 2 years and has been labeled a leukodystrophy because of an accompanying severe myelin deficit in the frontal lobes. Later onset forms have also been recognized based on the presence of abundant Rosenthal fibers. In these cases, clinical signs and pathology can be quite different from the infantile form, raising the question whether they share the same underlying cause. Recently, we and others have found pathogenic, de novo missense mutations in the glial fibrillary acidic protein gene in most infantile patients examined and in a few later onset patients. To obtain further information about the role of glial fibrillary acidic protein mutations in Alexander disease, we analyzed 41 new patients and another 3 previously described clinically, including 18 later onset patients. Our results show that dominant missense glial fibrillary acidic protein mutations account for nearly all forms of this disorder. They also significantly expand the catalog of responsible mutations, verify the value of magnetic resonance imaging diagnosis, indicate an unexpected male predominance for the juvenile form, and provide insights into phenotype–genotype relations. Ann Neurol 2005;57:310–326
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimate of the Mutation Rate per Nucleotide in Humans
Nachman, M. W., & Crowell, S. L. (2000) · Genetics · doi:10.1093/genetics/156.1.297 · Cited by 1,209
The CpG dinucleotide and human genetic disease
Cooper, D. N., & Youssoufian, H. (1988) · Human Genetics · doi:10.1007/bf00278187 · Cited by 931
Nomenclature for the description of human sequence variations
den Dunnen, J., & Antonarakis, S. (2001) · Human Genetics · doi:10.1007/s004390100505 · Cited by 896
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease
Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. E., & Messing, A. (2001) · Nature Genetics · doi:10.1038/83679 · Cited by 688
Self-citationαB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain
Iwaki, T., Kume-Iwaki, A., Liem, R. K. H., & Goldman, J. E. (1989) · Cell · doi:10.1016/0092-8674(89)90173-6 · Cited by 549
Self-citationFormaldehyde-mediated DNA-protein crosslinking: a probe for in vivo chromatin structures.
Solomon, M. J., & Varshavsky, A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6470 · Cited by 446
Mutations in the Rod Domains of Keratins 1 and 10 in Epidermolytic Hyperkeratosis
Rothnagel, J. A., Dominey, A. M., Dempsey, L. D., Longley, M. A., Greenhalgh, D. A., Gagne, T. A., Huber, M., Frenk, E., Hohl, D., & Roop, D. R. (1992) · Science · doi:10.1126/science.257.5073.1128 · Cited by 368
Keratin 16 and keratin 17 mutations cause pachyonychia congenita
McLean, W. H. I., Rugg, E. L., Lunny, D. P., Morley, S. M., Lane, E. B., Swensson, O., Dopping-Hepenstal, P. J. C., Griffiths, W. A. D., Eady, R. A. J., Higgins, C., et al. (1995) · Nature Genetics · doi:10.1038/ng0395-273 · Cited by 341
Alexander disease: diagnosis with MR imaging.
van der Knaap, M. S., Naidu, S., Breiter, S. N., Blasér, S., Stroink, H., Springer, S., Begeer, J. C., Coster, R. V., Barth, P. G., Thomas, N. H., et al. (2001) · PubMed Central · Cited by 338
Self-citationALEXANDER, W. S. (1949) · Brain · doi:10.1093/brain/72.3.373 · Cited by 303
Molecular architecture of intermediate filaments
Strelkov, S. V., Herrmann, H., & Aebi, U. (2003) · BioEssays · doi:10.1002/bies.10246 · Cited by 257
Optimisation of DNA and RNA extraction from archival formalin-fixed tissue
Coombs, N. J., Gough, A. C., & Primrose, J. N. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.16.e12-i · Cited by 254
Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK)
Reis, A., Hennies, H.-C., Langbein, L., Digweed, M., Mischke, D., Drechsler, M., Schröck, E., Royer-Pokora, B., Franke, W. W., Sperling, K., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-174 · Cited by 251
THE CYTOSKELETON AND DISEASE: Genetic Disorders of Intermediate Filaments
Fuchs, E. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.197 · Cited by 175
A functional "knockout" of human keratin 14.
Rugg, E. L., McLean, W. H., Lane, E. B., Pitera, R., McMillan, J. R., Dopping-Hepenstal, P. J., Navsaria, H. A., Leigh, I. M., & Eady, R. A. (1994) · Genes & Development · doi:10.1101/gad.8.21.2563 · Cited by 174
Smith, F. J. D., Corden, L. D., Rugg, E. L., Ratnavel, R., Leigh, I. M., Moss, C., Tidman, M. J., Hohl, D., Huber, M., Kunkeler, L., et al. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12335315 · Cited by 168
Iwaki, T., Iwaki, A., Tateishi, J., Sakaki, Y., & Goldman, J. E. (1993) · PubMed · Cited by 160
Self-citationRUSSO, L. S., Aron, A. M., & Anderson, P. J. (1976) · Neurology · doi:10.1212/wnl.26.7.607 · Cited by 152
Infantile Alexander Disease: Spectrum of GFAP Mutations and Genotype-Phenotype Correlation
Rodriguez, D., Gauthier‐Barichard, F., Bertini, E., Bugiani, M., Brenner, M., Tich, S. N. T., Goizet, C., Gélot, A., Surtees, R. A. H., Pédespan, J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323799 · Cited by 149
Self-citationGFAP mutations in Alexander disease
Li, R., Messing, A., Goldman, J. E., & Brenner, M. (2002) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00019-9 · Cited by 147
Self-citationShamsher, M. K., Navsaria, H. A., Stevens, H. P., Ratnavel, R. C., Purkis, P., Kelsell, D. P., McLean, W. H. I., Cook, L. J., Griffiths, W. A. D., Gschmeissner, S., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1875 · Cited by 125
Tomokane, N., Iwaki, T., Tateishi, J., Iwaki, A., & Goldman, J. E. (1991) · PubMed Central · Cited by 121
Self-citationJonkman, M. F., Heeres, K., Pas, H. H., et al. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365805 · Cited by 112
Identification of GFAP gene mutation in hereditary adult‐onset Alexander's disease
Namekawa, M., Takiyama, Y., Aoki, Y., Takayashiki, N., Sakoe, K., Shimazaki, H., Taguchi, T., Tanaka, Y., Nishizawa, M., Saito, K., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10375 · Cited by 111
Torchard, D., Blanchet‐Bardon, C., Serova, O., Langbein, L., Narod, S. A., Janin, N., Goguel, A., Bernheim, A., Franke, W. W., Lenoir, G., et al. (1994) · Nature Genetics · doi:10.1038/ng0194-106 · Cited by 106
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients
Gorospe, J. R. M., Naidu, S., Johnson, T., Puri, V., Raymond, G. V., Jenkins, S., Pedersen, R. C., Lewis, D., Knowles, P. D., Fernandez, R., et al. (2002) · Neurology · doi:10.1212/wnl.58.10.1494 · Cited by 104
Self-citationAdult Alexander Disease With Autosomal Dominant Transmission
Stumpf, E., Masson, H., Duquette, A., Berthelet, F., McNabb, J., Lortie, A., Lesage, J., Montplaisir, J. Y., Brais, B., & Cossette, P. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1307 · Cited by 95
Brenner, C. (2001) · Nature Genetics · doi:10.1038/87020 · Cited by 93
Wu, K. C., Bryan, J. T., Morasso, M. I., Jang, S.-I., Lee, J., Yang, J., Marekov, L. N., Parry, D. A. D., & Steinert, P. M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3539 · Cited by 88
Autosomal dominant palatal myoclonus and spinal cord atrophy
Okamoto, Y., Mitsuyama, H., Jonosono, M., Hirata, K., Arimura, K., Osame, M., & Nakagawa, M. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00687-6 · Cited by 86
Alexander Disease: New Insights From Genetics
Messing, A., Goldman, J. E., Johnson, T., & Brenner, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.6.563 · Cited by 81
Self-citationAlexander's Disease: Clinical, Pathologic, and Genetic Features
Johnson, T., & Brenner, M. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180090901 · Cited by 80
Self-citationCharacterization of human cDNA and genomic clones for glial fibrillary acidic protein
Brenner, M., Lampel, K. A., Nakatani, Y., Mill, J. F., Banner, C., Mearow, K. M., Dohadwala, M., Lipsky, R. H., & Freese, E. (1990) · Molecular Brain Research · doi:10.1016/0169-328x(90)90078-r · Cited by 78
Self-citationBongcam‐Rudloff, E., Nistér, M., Betsholtz, C., Wang, J., Stenman, G., Huebner, K., Croce, C. M., & Westermark, B. (1991) · PubMed · Cited by 77
The separation of transcriptionally engaged genes.
Ip, Y. T., Jackson, V. E., Meier, J. L., & Chalkley, R. G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68182-7 · Cited by 51
Thyagarajan, D. E., Chataway, T., Li, R., et al. (2004) · Movement Disorders · doi:10.1002/mds.20161 · Cited by 51
Self-citationSchuilenga‐Hut, P. H. L., van der Vlies, P., Jonkman, M. F., et al. (2003) · Human Mutation · doi:10.1002/humu.9124 · Cited by 50
A Novel Mutation in the Keratin 13 Gene Causing Oral White Sponge Nevus
Terrinoni, A., Rugg, E. L., Lane, E. B., Melino, G., Felix, D. H., Munro, C. S., & McLean, W. H. I. (2001) · Journal of Dental Research · doi:10.1177/00220345010800031401 · Cited by 47
Detection of protein kinase activity specifically activated at metaphase-anaphase transition.
Sekimata, M., Tsujimura, K., Tanaka, J., Takeuchi, Y., Inagaki, N., & Inagaki, M. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.132.4.635 · Cited by 47
Cummins, R. E., Klingberg, S. L., Wesley, J., Rogers, M., Zhao, Y., & Murrell, D. F. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01508.x · Cited by 44
Effect of NGF and Neurotrophin-3 Treatment on Experimental Diabetic Autonomic Neuropathy
Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., Parvin, C. A., & Escandón, E. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.263 · Cited by 36
Identification of two novel mutations in keratin 13 as the cause of white sponge naevus
Rugg, E. L., Magee, G. J., Wilson, N., Brandrup, F., Hamburger, J., & Lane, E. B. (1999) · Oral Diseases · doi:10.1111/j.1601-0825.1999.tb00097.x · Cited by 23
Cited by
Mechanisms of Disease: astrocytes in neurodegenerative disease
Maragakis, N. J., & Rothstein, J. D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0355 · Cited by 812
Astrocyte–neuron metabolic relationships: for better and for worse
Allaman, I., Bélanger, M., & Magistretti, P. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.12.001 · Cited by 639
Seizure‐Promoting Effect of Blood–Brain Barrier Disruption
Marchi, N., Angelov, L., Masaryk, T., Fazio, V., Granata, T., Hernandez, N., Hallene, K., Diglaw, T., Franic, L., Najm, I., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00988.x · Cited by 508
Astrocytes in Neurodegenerative Disease: Table 1.
Phatnani, H., & Maniatis, T. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020628 · Cited by 420
Remyelination in the central nervous system
Franklin, R. J. M., Bodini, B., & Goldman, S. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041371 · Cited by 40
Metadata
- Authors
- Li, R., Johnson, A. B., Salomons, G., Goldman, J. E., Naidu, S., Quinlan, R., Cree, B., Ruyle, S. Z., Banwell, B., D'Hooghe, M., Siebert, J. R., Rolf, C. M., Cox, H., Reddy, A., Gutiérrez‐Solana, L. G., Collins, A., Weller, R. O., Messing, A., van der Knaap, M. S., & Brenner, M.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2005-02-24
- Volume
- 57
- Issue
- 3
- Pages
- 310-326
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2063377136
- Cited by
- 269
- References
- 42
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.